SavedAdd your journal

Journals / Koşuyolu Heart Journal / 2018 / Cilt: 21 - Sayı: 1

Successful Surgical Pulmonary Embolectomy for Massive Pulmonary Embolism with Multiple Thrombogenic Risk Factors: A Case Report

Çoklu Trombojenik Risk Faktörüne Sahip Masif Pulmoner Emboli Olgusunun Başarılı Bir Şekilde Cerrahi Pulmoner Embolektomi ile Tedavisi: Olgu Sunumu

Hakan FOTBOLCU
Erhan KAYA
Yeşim DEMİREL BARUT
Ömer IŞIK
Cevat YAKUT
Pages
72–74
Publication Date
2018-04-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Furthermore, surgical pulmonary embolectomy remains one of the most effective treatment methods.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We report a 36-year old woman who suffered from massive pulmonary embolism with multiple thrombogenic risk factors.
📊
Key Findings & Data:She was successfully treated with pulmonary embolectomy.
💡
Conclusion & Impact:Furthermore, surgical pulmonary embolectomy remains one of the most effective treatment methods.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Masif pulmoner embolizm · çoklu trombojenik risk faktörü · cerrahi pulmoner embolektomi

Abstract

We report a 36-year old woman who suffered from massive pulmonary embolism with multiple thrombogenic risk factors. She was successfully treated with pulmonary embolectomy. Our report reinforces the importance of early diagnosis in the presence of a high clinical suspicion for pulmonary embolism. Furthermore, surgical pulmonary embolectomy remains one of the most effective treatment methods.

Özet

Otuz altı yaşında, çoklu trombojenik risk faktörüne sahip ve masif pulmoner emboli tablosu ile başvuran hastanın pulmoner embolektomi ile başarılı bir şekilde tedavi edilişini sunuyoruz. Olgumuz pulmoner emboli de erken tanının önemini belirtmektedir. Ayrıca, cerrahi pulmoner embolektominin en etkin tedavi yöntemlerinden biri olduğunu vurgulamaktadır.

🔖

Cite This Article

FOTBOLCU, H., KAYA, E., BARUT, Y. D., IŞIK, Ö., YAKUT, C. (2018). Successful Surgical Pulmonary Embolectomy for Massive Pulmonary Embolism with Multiple Thrombogenic Risk Factors: A Case Report. Koşuyolu Heart Journal, Cilt: 21 - Sayı: 1, 72–74. https://ajindex.com/articles/86487

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Walther A, Böttiger BW. Pulmonary embolism. Wien Med Wochenschr 2008;158:610-4
  2. Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 19791998: an analysis using multiplecause mortality data. Arch Intern Med 2003;163:1711-7
  3. Goldhaber SZ. Pulmonary embolism. Lancet 2004;363:1295-305
  4. Kline JA, Hernandez Nino J, Jones AE, Rose GA, Norton HJ, Camargo CA Jr. Prospective study of the clinical features and outcomes of emergency department patients with delayed diagnosis of pulmonary embolism. Acad Emerg Med 2007;14:592-8
  5. Mullins MD, Becker DM, Hagspiel KD, Philbrick JT. The role of spiral volumetric computed tomography in the diagnosis of pulmonary embolism. Arch Intern Med 2000;160:293-8
  6. Perrier A, Howarth N, Didier D, Loubeyre P, Unger PF, de Moerloose P, et al. Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism. Ann Intern Med 2001;135:88-97
  7. Kujovich JL. Factor V Leiden thrombophilia. Genet Med 2011;13:1-16
  8. Yusuf M, Gupta A, Kumar A, Afreen S. Mechanism and pathophysiology of activated protein C-related factor V leiden in venous thrombosis. Asian J Transfus Sci 2012;6:47-8
  9. Ornstein DL, Cushman M. Cardiology patient page. Factor V Leiden. Circulation 2003;107:e94-7
  10. Lauque D, Mazières J, Rouzaud P, Sié P, Chamontin B, Carrié D, et al. Pulmonary embolism in patients using estrogenprogestagen contraceptives. Presse Med 1998;27:15669
  11. Lehmann R, Suess C, Leus M, Luxembourg B, Miesbach W, Lindhoff-Last E, et al. Incidence, clinical characteristics and longterm prognosis of travelassociated pulmonary embolism. Eur Heart J 2009;30:23341
  12. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/nonST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000;284:83542
  13. Manzoli L, De Vito C, Marzuillo C, Boccia A, Villari P. Oral contraceptives and venous thromboembolism: a systematic review and metaanalysis. Drug Saf 2012;35:191205
  14. Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, et al. Screening for thrombophilia in highrisk situations: systematic review and costeffectiveness analysis. The thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study. Health Technol Assess 2006;10:10010
  15. Gruettner J, Viergutz T, Bolte M, Henzler T, Schoenberg SO, Sudarski S, et al. Importance of risk factors for the evaluation of